Stay updated on Anti-IgE MAb in Allergic Asthma Clinical Trial
Sign up to get notified when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.

Latest updates to the Anti-IgE MAb in Allergic Asthma Clinical Trial page
- Check6 days agoChange DetectedThe record for the CMAB007 allergic asthma clinical trial has been replaced by a 403 Forbidden error. An NIH websites transition notice is also displayed.SummaryDifference21%

- Check13 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details, indicating the resource is currently inaccessible. This reflects a permissions/access issue on the site rather than a modification to the study data.SummaryDifference21%

- Check62 days agoChange DetectedA new revision tag v3.6.6 was added and the previous tag v3.6.5 was removed. This reflects a minor update to the page's underlying template or versioning rather than changes to the study information.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now displays the complete study record for the allergic asthma trial, including design, eligibility, outcomes, and locations, along with related metadata such as data-sharing plans and MeSH terms. This replaces the previous error page and presents the study information in full context.SummaryDifference62%

Stay in the know with updates to Anti-IgE MAb in Allergic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.